Drug-target complex specific antibodies: an interview with Michael Schwenkert (Bio-Rad)

In this interview we talk to Michael Schwenkert (Bio-Rad Laboratories) about the poster he presented at EBF 2017. He discusses how Bio-Rad makes neo-epitope specific antibodies against drug-target complexes, the challenges of bioanalytical assays in relation to antibody reagents, and how Bio-Rad is helping to advance the field of drug discovery and development.

Click here to download Bio-Rad’s amazing poster on “Drug-Target-Complex Specific Antibodies for Pharmacokinetic Analysis of Biotherapeutics” now!

For more information on Bio-Rad, please click here.